NA.NASDAQNano Labs LTD

20-F/A: Nano Labs Ltd Files Amendment No. 1 to 20-F Addressing SEC Comments

Sentiment:

Annual Results


Nano Labs Ltd files an amendment to its 2023 annual report to address SEC staff comments, with no modifications to the original financial statements.

Worse than expectedThe company reported a net loss of RMB254.4 million (US$35.9 million) in 2023, compared to net income of RMB31.1 million in 2022.The company's revenue decreased significantly from RMB983.2 million in 2022 to RMB78.3 million (US$11.1 million) in 2023.

Summary

  • Nano Labs Ltd filed Amendment No. 1 on Form 20-F/A to address comments from the SEC regarding its original filing on April 8, 2024.
  • The amendment does not modify or update the financial statements from the original filing and does not reflect any events occurring after April 8, 2024.
  • The filing includes certifications required under Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002.
  • The company had 37,242,359 Class A ordinary shares and 28,589,078 Class B ordinary shares outstanding as of the close of the period covered by the annual report, after giving effect to a 2-for-1 share consolidation effective January 31, 2024.
  • Citibank N.A. terminated the American depositary receipts facility for Nano Labs' American depositary shares, effective February 1, 2024.
  • The company completed a filing with the CSRC on January 9, 2024, for its follow-on offering on September 13, 2023.
  • In 2021, 2022 and 2023, the company transferred cash proceeds of US$21.1 million, US$24.3 million and US$17.5 million, respectively, to its PRC subsidiaries.
  • As of December 31, 2023, the company had a balance of borrowing of approximately RMB123.7 million (US$17.5 million) under a credit line.
  • The company and its independent registered public accounting firm identified one material weakness in its internal control over financial reporting related to a lack of sufficient accounting personnel with adequate knowledge in financial reporting in accordance with U.S. GAAP.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While the company is taking steps to address internal control weaknesses and has plans for future product launches, the significant net loss and revenue decline in 2023 raise concerns about its financial performance and future prospects. The regulatory risks associated with operating in China also contribute to a negative outlook.

Positives

  • The company is taking steps to address the identified material weakness in internal control over financial reporting by implementing training programs and hiring additional qualified personnel.

Negatives

  • The company identified a material weakness in its internal control over financial reporting related to a lack of sufficient accounting personnel with adequate knowledge in financial reporting in accordance with U.S. GAAP.
  • The company recorded net loss of RMB254.4 million (US$35.9 million) in 2023.

Risks

  • The company faces various legal and operational risks and uncertainties related to being based in and having significant operations in China.
  • The PRC government may intervene in or influence the company's operations at any time, which could result in a material change in operations and/or the value of Class A ordinary shares.
  • Uncertainties with respect to the enforcement of and changes in laws and regulations in China could have a material adverse effect on the company's business, results of operations, financial condition and future prospects.
  • The company's Class A ordinary shares will be delisted and prohibited from trading in the over-the-counter market under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect or investigate completely auditors located in China for two consecutive years.
  • The company may need to make material changes in its operations to comply with PRC requirements and/or the value of its Class A ordinary shares might be affected.
  • The company may be required to obtain additional licenses, permits, registrations, filings or approvals for its business operations in the future, and there is no assurance that it will be able to obtain or maintain such permissions.

Future Outlook

The company expects to launch Cuckoo 3.0 Series products in 2024 and has received certain advance payments from customers as of the date of this annual report. The company believes that its existing cash and cash equivalents together with its anticipated cash flows from operations will be sufficient to meet its anticipated cash needs for general corporate purposes for the next 12 months from the date of this annual report.

Industry Context

The announcement reflects the challenges faced by companies operating in the cryptocurrency and IC design industries, including regulatory scrutiny, market volatility, and technological advancements.

Comparison to Industry Standards

  • The company's reliance on a limited number of third-party foundries for IC fabrication is a common practice in the fabless semiconductor industry, similar to companies like AMD and NVIDIA, but it also exposes them to supply chain risks.
  • The identified material weakness in internal control over financial reporting is a concern, as effective internal controls are crucial for maintaining investor confidence and complying with regulatory requirements, similar to the challenges faced by other companies undergoing rapid growth or operating in complex regulatory environments.
  • The company's efforts to expand its business in overseas IC markets and diversify its product offerings are consistent with the strategies of other companies in the industry to mitigate risks associated with market volatility and regulatory changes, such as Bitmain and Canaan.

Legal Proceedings

  • A customer filed a claim against one of the company's subsidiaries in Singapore, alleging failure to make timely delivery and demanding a return of payments of US$300,000.
  • Three of the company's subsidiaries were named as defendants in a civil action in China, with the plaintiff seeking to rescind a sales contract and demanding a return of payments of RMB47,000,000.

Related Party Transactions

  • Jianping Kong and Qifeng Sun provided guarantees for the company's debts and provided interest-free loans that were subsequently converted into Class A ordinary shares.

Stakeholder Impact

  • Shareholders may be affected by the company's net loss and revenue decline in 2023.
  • Shareholders may be affected by the identified material weakness in internal control over financial reporting.
  • Shareholders may be affected by the regulatory risks associated with operating in China.
  • Customers may be affected by the company's ability to launch new products and maintain its supply chain.

Next Steps

  • The company intends to implement measures to address the material weakness in internal control over financial reporting.
  • The company expects to launch Cuckoo 3.0 Series products in 2024.
  • The company intends to explore additional market opportunities in overseas markets.

Key Dates

DateDescription
2023-12-29Citibank N.A. distributed a notification regarding the amendment to the deposit agreement and the termination of American depositary receipts facility for Nano Labs’ American depositary shares, effective from February 1, 2024.
2024-01-09Nano Labs completed the filing with the CSRC for its follow-on offering on September 13, 2023.
2024-01-31Nano Labs conducted a 2-to-1 share consolidation.
2024-02-01Termination of American depositary receipts facility for Nano Labs’ American depositary shares, effective.
2024-04-08Original filing date of the annual report on Form 20-F for the fiscal year ended December 31, 2023.

Keywords

Nano Labs, Form 20-F, Amendment, Financial Reporting, Internal Control, China, SEC, PCAOB, CSRC, Share Consolidation, Material Weakness

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.